Viewing Study NCT01523067


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-06-04 @ 6:53 PM
Study NCT ID: NCT01523067
Status: COMPLETED
Last Update Posted: 2013-01-04
First Post: 2012-01-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension
Sponsor: PhaseBio Pharmaceuticals Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Essential Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vasomera View
None PB1046 View
None Hypertension View